Literature DB >> 32368939

Office hysteroscopy in the management of women with postmenopausal bleeding.

P Giampaolino1, L Della Corte2, C Di Filippo2, A Mercorio2, S G Vitale3, G Bifulco2.   

Abstract

Postmenopausal bleeding (PMB) is a relevant aspect for health-care providers in clinical practice: the first objective is to rule out potential gynecological cancer. The purpose of this narrative review is to evaluate the role of office hysteroscopy in the management of PMB. Office hysteroscopy is a minimally invasive procedure allowing direct visualization of uterine pathology without the need for general anesthesia and the use of an operating room, generating cost savings and greater compliance among patients. Here, we focus on major intrauterine diseases (polyps, submucosal myomas, endometrial hyperplasia, and cancer) as causes of PMB. Office hysteroscopy appears to be safe and feasible, and could allow accurate diagnosis of intrauterine pathologies, especially that with a focal growth pattern, otherwise misdiagnosed with blinded procedures. However, studies focusing exclusively on postmenopausal women are still few, so further research, especially randomized controlled trials, is needed.

Entities:  

Keywords:  Postmenopausal vaginal bleeding; endometrial cancer; endometrial hyperplasia; myomas; office hysteroscopy; polyps; target eye biopsy; treatment

Mesh:

Year:  2020        PMID: 32368939     DOI: 10.1080/13697137.2020.1754389

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  4 in total

Review 1.  Abnormal Uterine Bleeding in Perimenopausal Women: The Role of Hysteroscopy and Its Impact on Quality of Life and Sexuality.

Authors:  Salvatore Giovanni Vitale; Rafał Watrowski; Fabio Barra; Maurizio Nicola D'Alterio; Jose Carugno; Thozhukat Sathyapalan; Ilker Kahramanoglu; Enrique Reyes-Muñoz; Li-Te Lin; Bulent Urman; Simone Ferrero; Stefano Angioni
Journal:  Diagnostics (Basel)       Date:  2022-05-09

2.  Oncological Safety of Diagnostic Hysteroscopy for Apparent Early-Stage Type II Endometrial Cancer: A Multicenter Retrospective Cohort Study.

Authors:  Hui Zhou; Kai-Fa Lai; Qian Xiang; Yu Xu; Qian-Wen Zhang; Cui Hu; Xi-Guang Mao; Cheng Chen; Wu Huang; Gong-Sheng Mi; Juan Shen; Yong Tian; Feng-Mei Ke
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

Review 3.  Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.

Authors:  Pierluigi Giampaolino; Valeria Cafasso; Dominga Boccia; Mario Ascione; Antonio Mercorio; Francesco Viciglione; Mario Palumbo; Paolo Serafino; Cira Buonfantino; Maria Chiara De Angelis; Paolo Verrazzo; Giovanna Grasso; Giuseppe Gullo; Giuseppe Bifulco; Luigi Della Corte
Journal:  Biomed Res Int       Date:  2022-09-27       Impact factor: 3.246

4.  Risk Assessment of Endometrial Hyperplasia or Endometrial Cancer with Simplified Ultrasound-Based Scoring Systems.

Authors:  Norbert Stachowicz; Agata Smoleń; Michał Ciebiera; Tomasz Łoziński; Paweł Poziemski; Dariusz Borowski; Artur Czekierdowski
Journal:  Diagnostics (Basel)       Date:  2021-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.